← daily scanner dashboard

#2 THC — TENET HEALTHCARE CORP

B_VCP_DEVELOPING | as of 2026-09-25 | automated relative priority, not a published Minervini point formula

Relative priority70.00
RS rating85.74
Fundamental strength83.33
VCP score84.13
Pivot distance4.03%
AV confirmation100.00%complete
Technical chart for THC

Trend Template

price_above_sma150_and_sma200PASS
sma150_above_sma200PASS
sma200_rising_1mPASS
sma50_above_sma150_and_sma200PASS
price_above_sma50PASS
price_at_least_30pct_above_52w_lowPASS
price_within_25pct_of_52w_highPASS
rs_rating_at_least_70PASS

Trend Template metrics

close259.71
sma50255.66
sma150215.59
sma200212.03
sma200_1m_ago205.53
pct_above_52w_low64.81
pct_below_52w_high8.25
rs_rating85.74

VCP conditions

coherent_contraction_sequencePASS
enough_contractionsPASS
successive_ranges_inside_firstPASS
successive_depths_contractingPASS
final_contraction_tightPASS
base_depth_okPASS
resistance_area_tightPASS
volume_dryupFAIL
atr_contractingFAIL
price_tightPASS
near_pivotPASS

VCP metrics

num_contractions2.00
contraction_depths_pct[10.44, 5.14]
depth_ratios_vs_prior[0.492]
target_depth_ratio_roughly_half0.50
max_allowed_depth_ratio0.80
base_high283.05
base_low253.51
base_depth_pct10.44
base_duration_weeks4.60
resistance_spread_pct4.39
volume_dryup_ratio_10d_vs_50d0.89
atr_pct_recent3.21
atr_pct_prior3.80
atr_contraction_ratio0.84
tight_10d_range_pct8.60
raw_contraction_count7.00
raw_depths_pct[18.58, 21.56, 7.25, 14.5, 6.94, 10.44, 5.14]
final_trough_age_bars8.00
selection_reasoncoherent_current_sequence
pivot_price270.61
distance_to_pivot_pct4.03
vcp_score_pct84.13
is_vcp_candidatePASS
breakout_on_volumeFAIL

Price / volume

return_1m_pct-5.28
return_3m_pct37.41
return_6m_pct32.87
return_12m_pct32.08
weighted_12m_momentum14.19
range_10d_pct8.60
range_20d_pct9.93
avg_volume_50d980,619
dollar_volume_50d254.68M
up_down_volume_ratio_50d1.44
accumulation_days_20d2.00
distribution_days_20d4.00

Fundamental overlay criteria

eps_growth_minimumPASS
sales_growth_positive_or_betterPASS
core_data_coveragePASS
eps_acceleratingPASS
sales_acceleratingPASS
gross_margin_improving—
operating_margin_improvingPASS

Minervini-oriented SEC fundamentals

eps_growth_yoy_pct213.38
eps_previous_q_yoy_growth_pct87.59
eps_acceleration_pts125.79
eps_annual_growth_pct-52.63
eps_cagr_3y_pct59.88
sales_growth_yoy_pct6.77
sales_previous_q_yoy_growth_pct2.78
sales_acceleration_pts4.00
sales_annual_growth_pct3.07
sales_cagr_3y_pct3.58
gross_margin_pct—
operating_margin_pct26.67
pretax_margin_pct—
net_margin_pct—
gross_margin_yoy_change_pts—
operating_margin_yoy_change_pts11.06
roe_latest_fy_pct—
current_ratio1.41
debt_to_equity_pct3.44
cash_to_debt13.56
shares_outstanding—
adjusted_eps_growth_yoy_pct—
earnings_surprise_pct—
eps_estimate_revision_30d_pct—
analyst_count—
institutional_ownership_pct—
institutional_qoq_change_pct—
management_guidance_revision_pct—

SEC data quality

core_coverage_pct80.00
missing_core_metrics["quarterly_net_income", "shares_outstanding"]
selected_sec_tags{"accounts_payable": "us-gaap:AccountsPayableCurrent", "accounts_receivable": "us-gaap:AccountsReceivableNetCurrent", "capex": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cash": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "cost_of_revenue": null, "current_assets": "us-gaap:AssetsCurrent", "current_liabilities": "us-gaap:LiabilitiesCurrent", "dividends_paid": null, "eps_basic": "us-gaap:EarningsPerShareBasic", "eps_diluted": "us-gaap:EarningsPerShareDiluted", "equity": "us-gaap:StockholdersEquity", "gross_profit": null, "inventory": "us-gaap:InventoryNet", "long_term_debt": "us-gaap:LongTermDebtNoncurrent", "long_term_debt_current": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "net_income": "us-gaap:NetIncomeLoss", "operating_cash_flow": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "operating_income": "us-gaap:OperatingIncomeLoss", "pretax_income": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "r_and_d": null, "revenue": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "sga": null, "share_repurchases": "us-gaap:PaymentsForRepurchaseOfCommonStock", "shares_outstanding": "dei:EntityCommonStockSharesOutstanding", "short_term_debt": "us-gaap:ShortTermBorrowings", "short_term_investments": "us-gaap:MarketableSecuritiesCurrent", "stock_based_comp": "us-gaap:ShareBasedCompensation", "total_assets": "us-gaap:Assets", "total_liabilities": "us-gaap:Liabilities", "weighted_avg_diluted_shares": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"}
unavailable_canonical_concepts["cost_of_revenue", "dividends_paid", "gross_profit", "r_and_d", "sga"]
warnings["Standalone Q4 income/EPS can be absent because 10-K statements are annual.", "Company-specific extension tags are not returned by CompanyFacts.", "Non-GAAP EPS, guidance, 13F ownership, Form 4 activity, and analyst estimates are separate modules."]

Reporting periods

latest_quarter_end2026-06-30
latest_quarter_filed2026-07-29
latest_fiscal_year_end2025-12-31
latest_balance_sheet_end2026-06-30

Company metadata

symbolTHC
cik70,318
company_nameTENET HEALTHCARE CORP
exchange—
sic8,062
sic_descriptionServices-General Medical & Surgical Hospitals, NEC
fiscal_year_end1,231
as_of2026-09-26
sourceSEC EDGAR CompanyFacts + Submissions

Alpha Vantage enrichment

latest_reported_date2026-07-22
latest_reported_eps6.12
latest_estimated_eps4.08
latest_earnings_surprise_pct50.00
avg_earnings_surprise_4q_pct22.88
positive_earnings_surprises_4q4.00
earnings_surprise_quarters_available4.00
reported_eps_yoy_growth_pct52.24
estimate_period2027-12-31
analyst_count_eps—
analyst_count_revenue—
eps_estimate_avg—
revenue_estimate_avg—
estimate_revision.eps_estimate_revision_up_trailing_7_days1.00
estimate_revision.eps_estimate_revision_up_trailing_30_days4.00
estimate_revision.eps_estimate_revision_down_trailing_30_days1.00
eps_revision_up_30d4.00
eps_revision_down_30d1.00
eps_revision_net_up_30d3.00
institutional.total_institutional_holders815.00
institutional.total_institutional_shares90.67M
institutional.holders_with_increased_holdings343.00
institutional.holders_with_decreased_holdings381.00
institutional.holders_with_unchanged_holdings91.00
institutional_holder_rows815.00
institutional_total_shares90.67M
endpoints_returned["EARNINGS", "EARNINGS_ESTIMATES", "INSTITUTIONAL_HOLDINGS"]

Alpha Vantage confirmation screen

latest_earnings_surprise_positivePASS
average_4q_earnings_surprise_positivePASS
positive_surprise_quartersPASS
analyst_coverage_present—
eps_revision_breadth_nonnegative_30dPASS
institutional_sponsorship_presentPASS

Alpha Vantage screen summary

statuscomplete
confirmation_score_pct100.00
available_criteria5.00
noteInformational post-Exp0 confirmation only; not part of validated Exp0 selection/ranking.

Alpha Vantage endpoint status

EARNINGScache_available
EARNINGS_ESTIMATEScache_available
INSTITUTIONAL_HOLDINGScache_available

Accepted VCP contractions

peak_datepeak_pricetrough_datetrough_pricedepth_pctdepth_ratio_vs_priorbars
2026-08-24283.052026-09-02253.5110.44—7.00
2026-09-10270.612026-09-15256.715.140.493.00

Recent SEC filings

formfiling_dateaccession_numberprimary_document
8-K2026-09-220001193125-26-397901d104323d8k.htm
8-K2026-09-080000070318-26-000040thc-20260908.htm
10-Q2026-07-290000070318-26-000037thc-20260630.htm
8-K2026-07-230000070318-26-000032thc-20260723.htm
8-K2026-05-290000070318-26-000028thc-20260527.htm
10-Q2026-04-300000070318-26-000026thc-20260331.htm
8-K2026-04-300000070318-26-000023thc-20260430.htm
8-K2026-04-100000070318-26-000019thc-20260409.htm
8-K2026-03-300000070318-26-000015thc-20260325.htm
10-K2026-02-170000070318-26-000012thc-20251231.htm
8-K2026-02-110000070318-26-000007thc-20260211.htm
8-K2026-02-020000070318-26-000003thc-20260127.htm

SEPA factors not covered by SEC + Yahoo

These remain manual or require another provider/module and are deliberately not guessed: